Current through Register Vol. 39, No. 6, September 16, 2024
(a) The family
child care home operator may provide care for a mildly sick infant or child
older than two months who has a Fahrenheit temperature less than 101 degrees
and for infants younger than two months who have a Fahrenheit temperature of
less than 100.4 any method including axillary or orally, and who remains
capable of participating in routine group activities; so long as the child does
not have any of the following:
(1) more than
two stools above the child's normal pattern and diarrhea is not contained by a
diaper or when toilet-trained children are having accidents;
(2) two or more episodes of vomiting within a
12 hour period;
(3) lice, exclusion
shall begin immediately upon identification until completion of first
treatment;
(4) scabies;
(5) known chicken pox or a rash suggestive of
chicken pox;
(6) tuberculosis,
until a health professional provides a written statement that the child is not
infectious;
(7) strep throat, until
12 hours after antibiotic treatment has started and no fever is
present;
(8) pertussis, until five
days after appropriate antibiotic treatment;
(9) hepatitis A virus infection, until one
week after onset of illness or jaundice;
(10) impetigo, exclusion may begin at the end
of the program day until treatment has started;
(11) a physician's or other health
professional's written order that the child be separated from other children;
or
(12) exclusion for symptoms not
included in this list shall be required if the symptoms prevent the child from
participating comfortably in activities as determined by staff members of the
program or the symptoms result in a need for care that is greater than the
staff members can provide without compromising the health and safety of other
children.
(b) The
following provisions apply to the administration of medication in family child
care homes:
(1) No prescription or
over-the-counter medication and no topical, non-medical ointment, repellent,
lotion, cream, fluoridated toothpaste or powder shall be administered to any
child:
(A) without written authorization from
the child's parent;
(B) without
written instructions from the child's parent, physician or other health
professional;
(C) in any manner not
authorized by the child's parent, physician or other health
professional;
(D) after its
expiration date;
(E) for
non-medical reasons, such as to induce sleep; or
(F) with a known allergy to the
medication.
(2)
Prescribed medications:
(A) shall be stored in
the original containers in which they were dispensed with the pharmacy
labels;
(B) if pharmaceutical
samples, shall be stored in the manufacturer's original packaging, shall be
labeled with the child's name, and shall be accompanied by written instructions
specifying:
(i) the child's name;
(ii) the names of the medication;
(iii) the amount and frequency of
dosage;
(iv) the signature of the
prescribing physician or other health professional;
(v) the date the instructions were signed by
the physician or other health professional; and
(vi) shall be administered according to the
prescription, using amount and frequency of dosage specified on the label;
and
(C) shall be
administered only to the child for whom they were prescribed.
(3) A parent's written
authorization for the administration of a prescription medication described in
Subparagraph (b)(2) of this Rule shall be valid for the length of time the
medication is prescribed to be taken.
(4) Over-the-counter medications, such as
cough syrup, decongestant, acetaminophen, ibuprofen, topical antibiotic cream
for abrasions, or medication for intestinal disorders shall be stored in the
manufacturer's original packaging on which the child's name is written or
labeled and shall be accompanied by written instructions specifying:
(A) the child's name;
(B) the names of the authorized
over-the-counter medication;
(C)
the amount and frequency of the dosages, which shall not exceed the amount and
frequency of the dosages on the manufacturer's label;
(D) the signature of the parent, physician or
other health professional; and
(E)
the date the instructions were signed by the parent, physician or other health
professional.
The permission to administer over-the-counter medications is
valid for up to 30 days at a time, except as allowed in Subparagraphs (b)(6),
(7), (8), and (9) of this Rule. Over-the-counter medications shall not be
administered on an "as needed" basis, other than as allowed in Subparagraphs
(b)(6), (7), (8), and (9) of this Rule.
(5) When questions arise concerning whether
any medication should be administered to a child, the caregiver may decline to
administer the medication without signed, written dosage instructions from a
licensed physician or authorized health professional.
(6) A parent may give a caregiver standing
authorization for up to six months to administer prescription or
over-the-counter medication to a child, when needed, for chronic medical
conditions such as asthma, and for allergic reactions. The authorization shall
be in writing and shall contain:
(A) the
child's name;
(B) the subject
medical conditions or allergic reactions;
(C) the names of the authorized
over-the-counter medications;
(D)
the criteria for the administration of the medication;
(E) the amount and frequency of the
dosages;
(F) the manner in which
the medication shall be administered;
(G) the signature of the parent;
(H) the date the authorization was signed by
the parent; and
(I) the length of
time the authorization is valid, if less than six months.
(7) A parent may give a caregiver standing
authorization for up to 12 months to apply over-the-counter, topical ointments,
topical teething ointment or gel, insect repellents, lotions, creams,
fluoridated toothpaste, and powders, such as sunscreen, diapering creams, baby
lotion, and baby powder, to a child, when needed. The authorization shall be in
writing and shall contain:
(A) the child's
name;
(B) the names of the
authorized ointments, repellents, lotions, creams, fluoridated toothpaste, and
powders;
(C) the criteria for the
administration of the ointments, repellents, lotions, creams, fluoridated
toothpaste, and powders;
(D) the
manner in which the ointments, repellents, lotions, creams, fluoridated
toothpaste, and powders shall be applied;
(E) the signature of the parent;
(F) the date the authorization was signed by
the parent; and
(G) the length of
time the authorization is valid, if less than 12 months.
(8) A parent may give a caregiver standing
authorization to administer a single weight-appropriate dose of acetaminophen
to a child in the event the child has a fever and a parent cannot be reached.
The authorization shall be in writing and shall contain:
(A) the child's name;
(B) the signature of the parent;
(C) the date the authorization was signed by
the parent;
(D) the date that the
authorization ends or a statement that the authorization is valid until
withdrawn by the parent in writing.
(9) A parent may give a caregiver standing
authorization to administer an over-the-counter medication as directed by the
North Carolina State Health Director or designee, when there is a public health
emergency as identified by the North Carolina State Health Director or
designee. The authorization shall be in writing, may be valid for as long as
the child is enrolled, and shall contain:
(A)
the child's name;
(B) the signature
of the parent;
(C) the date the
authorization was signed by the parent; and
(D) the date that the authorization ends or a
statement that the authorization is valid until withdrawn by the parent in
writing.
(10) Pursuant
to G.S.
110-102.1A, a caregiver may administer
medication to a child without parental authorization in the event of an
emergency medical condition when the child's parent is unavailable, and
providing the medication is administered with the authorization and in
accordance with instructions from a health care professional as defined in
Rule.0102(21) of this Chapter.
(11)
A parent may withdraw written authorization for the administration of
medications at any time in writing.
(12) Any medication remaining after the
course of treatment is completed, after authorization is withdrawn or after
authorization has expired shall be returned to the child's parents. Any
medication the parent fails to retrieve within 72 hours of completion of
treatment, or withdrawal of authorization, shall be discarded.
(13) Any time prescription or
over-the-counter medication is administered by a caregiver to children
receiving care, the following information shall be recorded:
(A) the child's name;
(B) the date medication given;
(C) the time medication given;
(D) the amount and type of medication given;
and
(E) the name and signature of
the person administering the medication.
This information shall be noted on a medication permission
slip, or on a separate form developed by the operator which includes the
required information. This information shall be available for review by the
Division during the time period the medication is being administered and for
six months after the medication is administered. No documentation shall be
required when items listed in Subparagraph (b)(7) of this Rule are applied to
children.
(14)
if medication is administered in error, whether administering the wrong dosage,
giving to the wrong child, or giving the incorrect type of medicine, the
operator shall:
(A) call 911 in accordance
with CPR or First Aid training recommendations;
(B) contact the child's parent;
(C) observe the child; and
(D) document the medication error in writing,
including:
(i) the child's name and date of
birth;
(ii) the type and dosage of
medication administered;
(iii) the
name of the person who administered the medication;
(iv) the date and time of the
error;
(v) the signature of the
operator and the parent;
(vi) the
actions taken by the operator following the error; and
(vii) the actions that will be taken by the
operator to prevent a future error.
This documentation shall be maintained in the child's
file.
Authority
G.S.
110-85;
110-88;
110-91(6);
110-102.1A;
143B-168.3;
Eff.
July 1, 1998;
Amended Eff. July 1, 2015; May 1, 2004; April 1,
2003; April 1, 2001;
Temporary Amendment Eff. September 23,
2016;
Readopted Eff. October 1,
2017.